BioAmber

Montreal, Canada Founded: 2008 • Age: 18 yrs
Manufactures bio succinic acid and 1,4 butanediol from agricultural raw materials.
Annual revenue - Latest available
Total funding $93.0M 5 rounds
Employees - Tracked headcount
Investors 7 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About BioAmber

BioAmber is a company based in Montreal (Canada) founded in 2008 by Nathan Johnson. It operates as a B2B. BioAmber has raised $92.99 million across 5 funding rounds from investors including LANXESS, Unigrains and Naxos Capital Partners. BioAmber operates in a competitive market with competitors including Anuvia Plant Nutrients, BiOWiSH, WISErg, PittMoss and Ostara, among others.

  • Headquarter Montreal, Canada
  • Founders Nathan Johnson
  • Stage Public
  • Sectors
    Chemicals & Materials
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Chemicals & Materials → Advanced & Functional Materials Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $92.99 M (USD)

    in 5 rounds

  • Latest Funding Round
    $7.04 M (USD), Post-IPO

    Feb 09, 2018

  • Investors
    LANXESS

    & 6 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of BioAmber

BioAmber has successfully raised a total of $92.99M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $7.04 million completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in BioAmber

BioAmber has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include LANXESS, Unigrains and Naxos Capital Partners.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Locked Locked Locked
Life Sciences sector focused early stage VC firm investing primarily in Europe
Locked Locked Locked
Corporate-backed venture capital firm focused on healthcare, IT, and multiple sectors
Locked Locked Locked
Premium access

Investor details for BioAmber

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BioAmber

Investments
Premium access

Investment portfolio details for BioAmber

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - BioAmber

Premium access

Detailed financials for BioAmber

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Bioamber Comparisons

BioAmber Primary company
Description
Manufactures bio succinic acid and 1,4 butanediol from agric...
Location
Montreal, Canada
Founded Year
2008
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for BioAmber

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of BioAmber

BioAmber operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anuvia Plant Nutrients, BiOWiSH, WISErg, PittMoss and Ostara, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of crop nutrition products from municipal bio-waste
Locked Locked Locked
Innovative organic solutions for waste management and agriculture are developed.
Locked Locked Locked
Crop nutrition products are manufactured from processed food waste.
Locked Locked Locked
Eco-friendly peat moss substitute is made from recycled paper.
Locked Locked Locked
Nutrient recovery from wastewater is facilitated for fertilizer production.
Premium access

Detailed competitors of BioAmber

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Bioamber

Premium access

Complete news archive for BioAmber

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioAmber

BioAmber was founded in 2008 and raised its 1st funding round 3 years after it was founded.

BioAmber is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.

Nathan Johnson is the current CEO of BioAmber. They have also founded this company.

BioAmber is a funded company, having raised a total of $92.99M across 5 funding rounds to date.

BioAmber, founded in 2008 in Montreal, Canada, focuses on chemicals, advancing biotech innovations, bio-based chemicals, and sustainable materials. Manufactures bio succinic acid and 1,4 butanediol from agricultural raw materials. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

BioAmber's top competitors include BiOWiSH, Ostara and WISErg.

BioAmber has 7 investors. Key investors include LANXESS, Unigrains, Naxos Capital Partners, Sofinnova, and Cliffton Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available